Detalhe da pesquisa
1.
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.
Ann Hematol
; 100(8): 2023-2029, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34110462
2.
A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain.
Eur J Haematol
; 103(4): 335-341, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278876
3.
The role of blood inflammatory markers in the preoperative diagnosis of acute appendicitis.
Int J Lab Hematol
; 46(1): 58-62, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644670
4.
Clinical Significance and Outcome in Patients with Asymptomatic Versus Symptomatic Subsegmental Pulmonary Embolism.
J Clin Med
; 12(4)2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36836176
5.
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel.
Anticancer Res
; 38(11): 6423-6429, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30396967
6.
The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Panminerva Med
; 59(3): 203-209, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185443